Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Teva
McKesson
Baxter
Farmers Insurance
Daiichi Sankyo

Generated: May 20, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,756,393

« Back to Dashboard

Which drugs does patent 6,756,393 protect, and when does it expire?

Patent 6,756,393 protects NUPLAZID and is included in two NDAs.

This patent has thirty-one patent family members in twenty countries.

Summary for Patent: 6,756,393
Title: Azacyclic compounds
Abstract:Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is adminstered to a patient in need of such treatment.
Inventor(s): Andersson; Carl-Magnus A. (Glostrup, DK), Croston; Glenn (San Diego, CA), Hansen; Eva L. (Glostrup, DK), Uldam; Allan Kjaersgaard (Glostrup, DK)
Assignee: Acadia Pharmaceuticals, Inc. (San Diego, CA)
Application Number:10/409,782
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 6,756,393
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 6,756,393

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Acadia Pharms Inc NUPLAZID pimavanserin tartrate CAPSULE;ORAL 210793-001 Jun 28, 2018 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Acadia Pharms Inc NUPLAZID pimavanserin tartrate TABLET;ORAL 207318-002 Jun 28, 2018 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Acadia Pharms Inc NUPLAZID pimavanserin tartrate TABLET;ORAL 207318-001 Apr 29, 2016 DISCN Yes No ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 6,756,393

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 348808 ➤ Sign Up
Australia 2005202257 ➤ Sign Up
Australia 4007201 ➤ Sign Up
Australia 780006 ➤ Sign Up
Brazil 0108977 ➤ Sign Up
Brazil PI0108977 ➤ Sign Up
Canada 2397981 ➤ Sign Up
Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Moodys
Fish and Richardson
Colorcon
Cipla
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.